FDA report urges stronger warnings for acetaminophen

05/27/2009 | Bloomberg

An FDA working group released a report urging reduced doses of drugs containing acetaminophen and warnings about liver injury linked to such drugs. The report, which also advises against using acetaminophen in nonprescription combination products such as Tylenol Cold, will be discussed by FDA advisory panels June 29 and 30.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI